Roger I. Hickling

Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients

P Kopelman, Andrew Bryson, Roger I. Hickling et al. · International Journal of Obesity · 2006 · 142 citations

Agriculture, Pharmacology, Pharmacotherapy +17

Weight Loss, HbA_1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo‐controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)

Peter Kopelman, H. Gerrit de Groot, Aila Rissanen et al. · Obesity · 2009 · 94 citations

Medicine, Endocrinology, Pharmacotherapy +17

Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation – a double‐blind, randomized, placebo‐controlled, study

Anthony Lembo, Filippo Cremonini, N. L. Meyers et al. · Alimentary Pharmacology & Therapeutics · 2010 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Clinical trial: renzapride therapy for constipation‐predominant irritable bowel syndrome – multicentre, randomized, placebo‐controlled, double‐blind study in primary healthcare setting

Arun George, N. L. Meyers, Roger I. Hickling · Alimentary Pharmacology & Therapeutics · 2008 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Olivanic acids and related compounds: total synthesis of (±)-PS-5 and (±)-6-epi PS-5

John H. Bateson, Roger I. Hickling, Patricia M. Roberts et al. · Journal of the Chemical Society Chemical Communications · 1980 · 27 citations

Natural Sciences, Chemistry, Organic Chemistry +6